About IRE
The Institute for Radioelements (IRE) is a public utility foundation primarily focused on producing radioisotopes for diagnostic and therapeutic applications in nuclear medicine. IRE is the global leader in Molybdenum-99 production, the parent isotope of metastable Technetium-99m, the most widely used isotope in nuclear medicine for various examinations (heart, bones, lungs, thyroid, brain, kidneys, etc.). Beyond its production activities, IRE contributes to environmental protection and monitoring through its IRE Lab division, offering services such as radioactivity measurement in various samples, radiological characterization of waste and contaminated materials, and consultancy and technical support in radiological and nuclear fields.
IRE ELiT, the innovation subsidiary founded in 2010, develops radiopharmaceuticals for cancer imaging and treatment. Together, IRE and IRE ELiT employ more than 270 people. More information: www.ire.eu
